forward logo.jpg
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
April 08, 2022 17:25 ET | Forward Pharma A/S
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
forward logo.jpg
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
September 06, 2021 10:21 ET | Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the...
forward logo.jpg
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
April 14, 2021 16:40 ET | Forward Pharma A/S
COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
forward logo.jpg
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
January 12, 2021 16:30 ET | Forward Pharma A/S
COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the...
forward logo.jpg
Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19
May 12, 2020 17:00 ET | Forward Pharma A/S
COPENHAGEN, Denmark, May 12, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to current precautionary measures against the...
forward logo.jpg
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019
April 24, 2020 16:50 ET | Forward Pharma A/S
COPENHAGEN, Denmark, April 24, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
forward logo.jpg
Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares
November 26, 2019 16:05 ET | Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of...
forward logo.jpg
Forward Pharma to Participate in the Fall Investor Summit in New York
September 05, 2019 08:30 ET | Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in...
forward logo.jpg
Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock Exchange
June 26, 2019 16:30 ET | Forward Pharma A/S
COPENHAGEN, Denmark, June 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced its intention to transfer its public listing of American Depositary Shares from...
forward logo.jpg
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018
April 04, 2019 16:30 ET | Forward Pharma A/S
COPENHAGEN, Denmark, April 04, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...